1. Home
  2. SCPH vs PBPB Comparison

SCPH vs PBPB Comparison

Compare SCPH & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • PBPB
  • Stock Information
  • Founded
  • SCPH 2013
  • PBPB 1977
  • Country
  • SCPH United States
  • PBPB United States
  • Employees
  • SCPH N/A
  • PBPB N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • PBPB Restaurants
  • Sector
  • SCPH Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • SCPH 299.0M
  • PBPB 305.0M
  • IPO Year
  • SCPH 2017
  • PBPB 2013
  • Fundamental
  • Price
  • SCPH $5.63
  • PBPB $17.00
  • Analyst Decision
  • SCPH Buy
  • PBPB Buy
  • Analyst Count
  • SCPH 3
  • PBPB 3
  • Target Price
  • SCPH $12.00
  • PBPB $17.37
  • AVG Volume (30 Days)
  • SCPH 2.3M
  • PBPB 1.5M
  • Earning Date
  • SCPH 11-12-2025
  • PBPB 11-06-2025
  • Dividend Yield
  • SCPH N/A
  • PBPB N/A
  • EPS Growth
  • SCPH N/A
  • PBPB N/A
  • EPS
  • SCPH N/A
  • PBPB 0.35
  • Revenue
  • SCPH $49,969,000.00
  • PBPB $469,138,000.00
  • Revenue This Year
  • SCPH $108.95
  • PBPB $5.28
  • Revenue Next Year
  • SCPH $78.30
  • PBPB $4.30
  • P/E Ratio
  • SCPH N/A
  • PBPB $49.07
  • Revenue Growth
  • SCPH 107.79
  • PBPB N/A
  • 52 Week Low
  • SCPH $1.94
  • PBPB $7.27
  • 52 Week High
  • SCPH $6.28
  • PBPB $17.04
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.37
  • PBPB 82.81
  • Support Level
  • SCPH $4.33
  • PBPB $12.38
  • Resistance Level
  • SCPH $5.62
  • PBPB $17.04
  • Average True Range (ATR)
  • SCPH 0.05
  • PBPB 0.31
  • MACD
  • SCPH 0.01
  • PBPB 0.49
  • Stochastic Oscillator
  • SCPH 93.75
  • PBPB 99.18

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: